BACKGROUND: Depression consistently predicts nonadherence to human immunodeficiency virus antiretroviral therapy, but which aspects of depression are most influential are unknown. Such knowledge could inform assessments of adherence readiness and the type of depression treatment to utilize. PURPOSE: We examined how depression severity, symptom type, and change over time relate to adherence. METHODS: Microelectronic adherence and self-reported depression data from 1,374 participants across merged studies were examined with cross-sectional and longitudinal analyses. Depression variables included a continuous measure, categorical measure of severity, cognitive and vegetative subscales, and individual symptoms. RESULTS: At baseline, mean adherence was 69%, and 25% had mild/moderate and 18% had severe depression. In cross-sectional multivariate analyses, continuous depression, cognitive depressive symptoms, and severe depression were associated with lower adherence. In longitudinal analysis, reductions in both continuous and categorical depression predicted increased adherence. CONCLUSIONS: The relationship between global continuous depression and nonadherence was statistically significant, but relatively weak compared to that of cognitive depressive symptoms and severe depression, which appear to pose strong challenges to adherence and call for the need for early detection and treatment of depression.
BACKGROUND:Depression consistently predicts nonadherence to human immunodeficiency virus antiretroviral therapy, but which aspects of depression are most influential are unknown. Such knowledge could inform assessments of adherence readiness and the type of depression treatment to utilize. PURPOSE: We examined how depression severity, symptom type, and change over time relate to adherence. METHODS: Microelectronic adherence and self-reported depression data from 1,374 participants across merged studies were examined with cross-sectional and longitudinal analyses. Depression variables included a continuous measure, categorical measure of severity, cognitive and vegetative subscales, and individual symptoms. RESULTS: At baseline, mean adherence was 69%, and 25% had mild/moderate and 18% had severe depression. In cross-sectional multivariate analyses, continuous depression, cognitive depressive symptoms, and severe depression were associated with lower adherence. In longitudinal analysis, reductions in both continuous and categorical depression predicted increased adherence. CONCLUSIONS: The relationship between global continuous depression and nonadherence was statistically significant, but relatively weak compared to that of cognitive depressive symptoms and severe depression, which appear to pose strong challenges to adherence and call for the need for early detection and treatment of depression.
Authors: Glenn J Wagner; David E Kanouse; Daniela Golinelli; Loren G Miller; Eric S Daar; Mallory D Witt; Catherine Diamond; Jeremiah G Tilles; Carol A Kemper; Robert Larsen; Miguel Goicoechea; Richard H Haubrich Journal: AIDS Date: 2006-06-12 Impact factor: 4.177
Authors: Michael H Antoni; Adam W Carrico; Ron E Durán; Susan Spitzer; Frank Penedo; Gail Ironson; Mary Ann Fletcher; Nancy Klimas; Neil Schneiderman Journal: Psychosom Med Date: 2006 Jan-Feb Impact factor: 4.312
Authors: B J Turner; J A Fleishman; N Wenger; A S London; M A Burnam; M F Shapiro; E G Bing; M D Stein; D Longshore; S A Bozzette Journal: J Gen Intern Med Date: 2001-09 Impact factor: 5.128
Authors: Jane M Simoni; David Huh; Ira B Wilson; Jie Shen; Kathy Goggin; Nancy R Reynolds; Robert H Remien; Marc I Rosen; David R Bangsberg; Honghu Liu Journal: J Acquir Immune Defic Syndr Date: 2012-08-15 Impact factor: 3.731
Authors: Matthew J Mimiaga; Katie Biello; Sari L Reisner; Heidi M Crane; Johannes Wilson; Chris Grasso; Mari M Kitahata; Wm Christopher Mathews; Kenneth H Mayer; Steven A Safren Journal: Health Psychol Date: 2015-02-02 Impact factor: 4.267
Authors: Vincent C Marconi; Baohua Wu; Jane Hampton; Claudia E Ordóñez; Brent A Johnson; Dinesh Singh; Sally John; Michelle Gordon; Anna Hare; Richard Murphy; Jean Nachega; Daniel R Kuritzkes; Carlos del Rio; Henry Sunpath Journal: AIDS Patient Care STDS Date: 2013-12 Impact factor: 5.078
Authors: Robert H Remien; Curtis Dolezal; Glenn J Wagner; Kathy Goggin; Ira B Wilson; Robert Gross; Marc I Rosen; Jie Shen; Jane M Simoni; Carol E Golin; Julia H Arnsten; David R Bangsberg; Honghu Liu Journal: AIDS Behav Date: 2014-08
Authors: Irma Eloff; Michelle Finestone; Jennifer D Makin; Alex Boeving-Allen; Maretha Visser; Liesel Ebersöhn; Ronél Ferreira; Kathleen J Sikkema; Margaret J Briggs-Gowan; Brian W C Forsyth Journal: AIDS Date: 2014-07 Impact factor: 4.177